MetaCap

Immunovant Statistics

NASDAQ: IMVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

31.77-0.75 (-2.31%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Immunovant by the numbers

Immunovant has a market capitalization of $6.57 billion based on 206.95M shares outstanding. With trailing EPS of $-2.56, Immunovant is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.9% below its 50-day average and 2.3% below its 200-day average.

Average daily trading volume is 1.42M shares, or about $45.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IMVT valuation vs. peer median

IMVT compared with the median of 8 peer companies
MetricIMVTPeer medianDifference
Market cap$6.57B$6.72B-2%
Avg. volume1.42M2.02M-30%

Peer median across 8 companies: IBRX, KOD, TWST, CGON, SRRK, ADPT, PCVX, KRYS.

Valuation

Price and trading

Previous close
32.52
Open
32.07
Day range
31.62 – 32.77
52-week range
21.93 – 45.42
52-week change
+40.64%
Beta
—
Volume
702.87K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
6.57B
Forward Pe
-11.26
Eps
-2.56
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
45.42
Week52 Low
21.93
Avg Volume
1.42M
Shares Outstanding
206.95M
Ma50
32.06
Ma200
32.53
Earnings Date
Nov 9, 2026
Pct From52w High
-30.05%
Pct From52w Low
44.87%

Related